omeprazole has been researched along with Aspergillus Infection in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Voriconazole is the preferred antifungal agent for Aspergillus infections." | 7.78 | Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections. ( Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL, 2012) |
| "To determine the effects of omeprazole on plasma voriconazole concentration in Thai patients who had invasive fungal diseases." | 3.81 | Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients. ( Chayakulkeeree, M; Maneerattanaporn, M; Poovipirom, N; Siengwattana, P, 2015) |
| "Voriconazole is the preferred antifungal agent for Aspergillus infections." | 3.78 | Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections. ( Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chayakulkeeree, M | 1 |
| Poovipirom, N | 1 |
| Siengwattana, P | 1 |
| Maneerattanaporn, M | 1 |
| Boyd, NK | 1 |
| Zoellner, CL | 1 |
| Swancutt, MA | 1 |
| Bhavan, KP | 1 |
2 other studies available for omeprazole and Aspergillus Infection
| Article | Year |
|---|---|
Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Dose-Response Relation | 2015 |
Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Administration Routes; Drug Adm | 2012 |